Do HEDIS measures reflect cost-effective practices?
Authors:
- Peter J NeumannPNPeter J Neumann
- Bat-Sheva LevineBLBat-Sheva Levine
- 30 November 2002
- journal article
- Published by Elsevier in American Journal of Preventive Medicine
- Vol. 23 (4) , 276-289
Abstract
No abstract availableKeywords
This publication has 134 references indexed in Scilit:
- A Predictive Model of the Health Benefits and Cost Effectiveness of Celiprolol and Atenolol in Primary Prevention of Cardiovascular Disease in Hypertensive PatientsPharmacoEconomics, 1997
- An Economic Analysis of the Survival and Ventricular Enlargement (SAVE) StudyPharmacoEconomics, 1997
- An Economic Evaluation of Finasteride for Treatment of Benign Prostatic HyperplasiaPharmacoEconomics, 1996
- In search of the best upper age limit for breast cancer screeningEuropean Journal of Cancer, 1995
- Cost Utility of Maintenance Treatment of Recurrent Depression with Sertraline Versus Episodic Treatment with DothiepinPharmacoEconomics, 1994
- A tentative cost—utility analysis of road safety educationAustralian Journal of Public Health, 1993
- Neonatal screening for sickle cell disease: A cost-effectiveness analysisThe Journal of Pediatrics, 1991
- The Differential Effect of Prenatal Care on the Incidence of Low Birth Weight among Blacks and Whites in a Prepaid Health Care PlanNew England Journal of Medicine, 1988
- Cost Effectiveness of Vaccination against Pneumococcal PneumoniaNew England Journal of Medicine, 1980
- Estrogen Use in Postmenopausal Women — Costs, Risks, and BenefitsNew England Journal of Medicine, 1980